Clinical Trial
doi: 10.1136/pgmj.62.723.19.
Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration
- PMID: 3540918
- PMCID: PMC2418563
- DOI: 10.1136/pgmj.62.723.19
Item in Clipboard
Clinical Trial
Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration
Postgrad Med J.
1986 Jan.
Abstract
Fifty three patients with endoscopically proven duodenal ulceration have cooperated in a clinical trial to compare the ulcer healing effect of tripotassium dicitrato bismuthate (TDB) at standard dosage administered either twice or four times daily. No statistically significant difference has been found to exist between ulcer healing in the two groups at 4 weeks (72% and 67%, P = 0.944) or at 8 weeks (92% and 81%, P = 0.504) and it is concluded that twice daily TDB maintains the effectiveness of the drug and has advantages for patient compliance.
Similar articles
-
Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.N Z Med J. 1985 Mar 27;98(775):191-2. N Z Med J. 1985. PMID: 3885084 Clinical Trial.
-
Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.Gut. 1983 Dec;24(12):1148-51. doi: 10.1136/gut.24.12.1148. Gut. 1983. PMID: 6357964 Free PMC article. Clinical Trial.
-
Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.Gut. 1984 Jul;25(7):703-6. doi: 10.1136/gut.25.7.703. Gut. 1984. PMID: 6376292 Free PMC article. Clinical Trial.
-
Review article: safety of bismuth in the treatment of gastrointestinal diseases.Aliment Pharmacol Ther. 1996 Aug;10(4):459-67. doi: 10.1046/j.1365-2036.1996.22163000.x. Aliment Pharmacol Ther. 1996. PMID: 8853750 Review.
-
What is an intractable duodenal ulcer and how should it be managed?Aliment Pharmacol Ther. 1987;1 Suppl 1:439S-446S. doi: 10.1111/j.1365-2036.1987.tb00654.x. Aliment Pharmacol Ther. 1987. PMID: 2979695 Review.
Cited by
-
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.Gut. 1990 Sep;31(9):999-1002. doi: 10.1136/gut.31.9.999. Gut. 1990. PMID: 2210469 Free PMC article.
-
Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.Drugs. 1988 Aug;36(2):132-57. doi: 10.2165/00003495-198836020-00002. Drugs. 1988. PMID: 3053124 Review.
